Furthermore, the effect of Hsp70 inhibitors was demonstrated in preventing the risk of tumor recurrence in in vivo models by uncoupling the Hsp70-HMGB1 complex, which was shown to exert pro-tumor activity [31]. The gene discussed is HMGB1; the disease is neoplasm.